P.A.W. Capital Corp increased its holdings in R1 RCM Inc (NASDAQ:RCM) by 8.1% in the first quarter, HoldingsChannel.com reports. The firm owned 400,000 shares of the financial services provider’s stock after buying an additional 30,000 shares during the quarter. R1 RCM makes up 3.8% of P.A.W. Capital Corp’s holdings, making the stock its 6th biggest holding. P.A.W. Capital Corp’s holdings in R1 RCM were worth $3,868,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. PNC Financial Services Group Inc. grew its position in shares of R1 RCM by 64.5% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,463 shares of the financial services provider’s stock valued at $59,000 after purchasing an additional 2,926 shares in the last quarter. Bank of Montreal Can lifted its position in shares of R1 RCM by 1,501.7% during the 4th quarter. Bank of Montreal Can now owns 11,388 shares of the financial services provider’s stock valued at $90,000 after acquiring an additional 10,677 shares during the period. Falcon Point Capital LLC purchased a new position in shares of R1 RCM during the 4th quarter worth approximately $112,000. Cim LLC purchased a new position in shares of R1 RCM during the 4th quarter worth approximately $120,000. Finally, Amalgamated Bank purchased a new position in shares of R1 RCM during the 4th quarter worth approximately $123,000. 65.82% of the stock is owned by institutional investors.
Several analysts have commented on RCM shares. BidaskClub raised shares of R1 RCM from a “hold” rating to a “buy” rating in a research note on Wednesday, February 20th. Zacks Investment Research raised shares of R1 RCM from a “hold” rating to a “buy” rating and set a $11.00 price objective for the company in a research note on Saturday, March 2nd. KeyCorp began coverage on shares of R1 RCM in a research note on Tuesday, January 22nd. They set an “overweight” rating and a $10.00 price objective for the company. Finally, Cantor Fitzgerald boosted their price objective on shares of R1 RCM from $11.00 to $13.00 and gave the company an “overweight” rating in a research note on Friday, April 12th. Five research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $14.20.
Shares of NASDAQ RCM opened at $10.56 on Wednesday. R1 RCM Inc has a 52-week low of $7.10 and a 52-week high of $11.32. The firm has a market cap of $1.17 billion, a PE ratio of -33.00 and a beta of 0.11. The company has a debt-to-equity ratio of 56.51, a current ratio of 1.00 and a quick ratio of 1.00.
R1 RCM (NASDAQ:RCM) last announced its quarterly earnings data on Friday, February 22nd. The financial services provider reported ($0.02) earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.02). R1 RCM had a negative net margin of 5.22% and a negative return on equity of 145.94%. The company had revenue of $262.90 million during the quarter, compared to analysts’ expectations of $264.48 million. The firm’s quarterly revenue was up 87.4% compared to the same quarter last year. As a group, sell-side analysts expect that R1 RCM Inc will post 0.25 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “P.A.W. Capital Corp Has $3.87 Million Position in R1 RCM Inc (RCM)” was originally published by Zolmax and is the sole property of of Zolmax. If you are viewing this story on another publication, it was illegally copied and republished in violation of US & international trademark & copyright law. The original version of this story can be read at https://zolmax.com/investing/p-a-w-capital-corp-has-3-87-million-position-in-r1-rcm-inc-rcm/3042034.html.
R1 RCM Profile
R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.
Featured Story: What is the Dividend Aristocrat Index?
Want to see what other hedge funds are holding RCM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for R1 RCM Inc (NASDAQ:RCM).
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.